ROODOLPH JOSEPH: Open Payments
NPI 1114499779 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 42 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,097
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $188 |
| GlaxoSmithKline, LLC. | 6 | $165 |
| AstraZeneca Pharmaceuticals LP | 7 | $160 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $148 |
| CSL Behring | 4 | $129 |
| GENZYME CORPORATION | 3 | $112 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Baxter Healthcare | 1 | $27 |
| Paratek Pharmaceuticals, Inc. | 1 | $27 |
| Organon LLC | 1 | $25 |
Products named: DUPIXENT, NUCALA, Hizentra, TEZSPIRE, TAKHZYRO, FASENRA, HYQVIA, Rhapsido.
Industry payments across RI — which companies pay providers there.
